No Benefit to Adding ICI to Chemo in TNBC ...Middle East

Medscape - News
The Michelangelo trial revealed that adding atezolizumab to nab-paclitaxel and carboplatin did not improve 5-year event-free survival in patients with triple-negative breast cancer. MDedge News

Hence then, the article about no benefit to adding ici to chemo in tnbc was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( No Benefit to Adding ICI to Chemo in TNBC )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News